Methylphenidate Hydrochloride Extended-Release 10 mg/1 (Methylphenidate Hydrochloride CAPSULE, EXTENDED RELEASE) 10 mg/1

Methylphenidate Hydrochloride works by inhibiting the reuptake of dopamine and norepinephrine in the brain. This increases the concentrations of these neurotransmitters in the synaptic cleft, enhancing neurotransmission. This mechanism helps improve focus and reduce hyperactivity and impulsivity in patients with ADHD, and promotes wakefulness in patients with narcolepsy.

The dosage of Methylphenidate Hydrochloride Extended-Release 10 mg/1 is determined by a healthcare provider based on the patient's age, weight, and specific medical condition. It is important to follow the prescribed dosage and not to adjust it without consulting a healthcare professional.

Methylphenidate Hydrochloride is classified as a pregnancy category C drug, meaning it should be used during pregnancy only if the potential benefits outweigh the risks. It is not recommended for use during breastfeeding as it may pass into breast milk. Always consult a healthcare provider for personalized advice.

To order Methylphenidate Hydrochloride Extended-Release 10 mg/1 from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the necessary import paperwork.

Methylphenidate Hydrochloride is one of the most commonly prescribed medications for ADHD. It is a central nervous system stimulant, similar to other medications like amphetamines. However, it has a different chemical structure and mechanism of action, which may make it more suitable for some patients. The choice of medication depends on individual patient response and side effect profile.

Methylphenidate Hydrochloride Extended-Release 10 mg/1 should be stored below 25°C, in the original pack, and protected from moisture. Keep the medication out of reach of children and pets to prevent accidental ingestion. Always follow the storage instructions provided by the manufacturer and healthcare provider.

Methylphenidate Hydrochloride Extended-Release 10 mg/1 is administered orally, typically once daily in the morning. The capsules should be swallowed whole with water and not chewed or crushed to ensure the extended-release mechanism works properly. Always follow the administration instructions provided by your healthcare provider.

The most serious risks associated with Methylphenidate Hydrochloride include cardiovascular issues such as increased blood pressure and heart rate, psychiatric effects like anxiety and hallucinations, and the potential for seizures, especially in patients with a history of seizures. Allergic reactions, though rare, can also occur and may include rash, itching, or swelling.

Methylphenidate Hydrochloride Extended-Release 10 mg/1 should not be used by individuals with certain medical conditions, such as severe anxiety, agitation, or a history of heart problems. It is also not recommended for patients with glaucoma, tics, or a history of drug abuse. Always consult a healthcare provider to determine if this medication is suitable for you.